GreenLight Biosciences Holdings, PBC

Overview

• IndustryBiological Products, (No Diagnostic Substances)¹
• HeadquartersLexington, Massachusetts¹
• Incorporated inDE²
• Business address29 Hartwell Avenue, Lexington, Ma 02421²
• Filer category, Emerging growth company²

See how the biggest companies compare on our leaderboards

Corporate structure

GreenLight Biosciences Holdings, PBC sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What GreenLight Biosciences Holdings, PBC reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

Investments

Leadership

Who has led GreenLight Biosciences Holdings, PBC, and when. Pick a name to see everywhere that person has worked.

• Chief executive officerJuan Andrey Zarur Feb 4, 2022 to Jul 26, 2023⁸
• Chief executive officerDaniel Robert Coyne Jan 15, 2021 to Jan 15, 2021⁹
• PresidentJuan Andrey Zarur Feb 4, 2022 to Jul 26, 2023⁸
• Chief financial officerSusan Keefe Feb 4, 2022 to Aug 8, 2022¹⁰
• Chief financial officerJennifer E. Pardi Jan 13, 2021 to Jan 13, 2021¹¹
• Chief operating officerCarole B. Cobb Feb 4, 2022 to Aug 8, 2022¹²

Former names

• Environmental Impact Acquisition CorpSep 18, 2020 to Feb 3, 2022²

Timeline

1. Jul 28, 20238-K Completed an acquisition or sale; Listing notice or transfer; Change to shareholders' rights²⁶
2. Jul 24, 20238-K Completed an acquisition or sale; Listing notice or transfer; Change to shareholders' rights²⁷
3. Jul 13, 20238-K Entered a material agreement; New debt or obligation; Other events²⁸
4. May 31, 20238-K Exit or restructuring costs²⁹
5. May 30, 20238-K Entered a material agreement; New debt or obligation; Other events³⁰
6. May 11, 20238-K Results of operations³¹
7. Mar 30, 20238-K Regulation FD disclosure³²
8. Mar 28, 20238-K Results of operations³³
9. Mar 9, 20238-K Regulation FD disclosure; Other events³⁴
10. Mar 7, 20238-K Regulation FD disclosure; Other events³⁵
11. Feb 1, 20238-K Regulation FD disclosure; Other events³⁶
12. Jan 9, 20238-K Entered a material agreement; Regulation FD disclosure³⁷
13. Feb 4, 2022New chief executive Juan Andrey Zarur becomes CEO⁸
14. Jan 15, 2021New chief executive Daniel Robert Coyne becomes CEO⁹

Calendar

When it reported results

1. May 11, 2023Reported quarterly or annual results³¹
2. Mar 28, 2023Reported quarterly or annual results³³
3. Nov 9, 2022Reported quarterly or annual results³⁸

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

304 filings to the SEC since October 2021: 2 annual reports, 7 quarterly reports, 27 major events, 131 insider forms, 67 large holders, 70 other. The latest 20:

1. Aug 11, 202315-12G EDGAR
2. Jul 28, 20238-K/A EDGAR
3. Jul 28, 2023SC 13D/A EDGAR
4. Jul 28, 2023SC 13D/A AMENDMENT TO SCHEDULE 13D EDGAR
5. Jul 27, 20234 PRIMARY DOCUMENT EDGAR
6. Jul 27, 20234 PRIMARY DOCUMENT EDGAR
7. Jul 27, 20234 PRIMARY DOCUMENT EDGAR
8. Jul 27, 2023SC 13D/A EDGAR
9. Jul 27, 2023SC 13D/A EDGAR
10. Jul 27, 20234 EDGAR
11. Jul 27, 20233 EDGAR
12. Jul 26, 20234 PRIMARY DOCUMENT EDGAR
13. Jul 26, 20234 PRIMARY DOCUMENT EDGAR
14. Jul 26, 20234 PRIMARY DOCUMENT EDGAR
15. Jul 26, 20234 PRIMARY DOCUMENT EDGAR
16. Jul 26, 20234 PRIMARY DOCUMENT EDGAR
17. Jul 26, 20234 PRIMARY DOCUMENT EDGAR
18. Jul 26, 20234 PRIMARY DOCUMENT EDGAR
19. Jul 26, 20234 PRIMARY DOCUMENT EDGAR
20. Jul 26, 20234 PRIMARY DOCUMENT EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

9 open-market trades by officers, directors and large owners since October 2021: 8 buys and 1 sales. Grants, option exercises and gifts are left out.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

• Boscolo Intervest LtdSC 13D/A, 2 filings Jun 9, 2023 to Jul 28, 2023³⁹
• Pharma S.l. InsudSC 13D/A, 2 filings Jun 8, 2023 to Jul 28, 2023⁴⁰
• Builders Vision, LLCSC 13D/A, 4 filings Feb 11, 2022 to Jul 27, 2023⁴¹
• KODIAK VENTURE PARTNERS III LPSC 13D/A, 3 filings Feb 11, 2022 to Jul 27, 2023⁴²
• CONTINENTAL GRAIN COSC 13D/A, 2 filings Jun 8, 2023 to Jul 26, 2023⁴³
• Jeremy & Hannelore Grantham Environmental TrustSC 13D/A, 2 filings Jun 7, 2023 to Jul 26, 2023⁴⁴
• MLS Capital Fund II LPSC 13D/A, 2 filings Jun 6, 2023 to Jul 26, 2023⁴⁵
• Of Trustees Of The Leland Stanford Junior University BoardSC 13D/A, 2 filings Jun 8, 2023 to Jul 26, 2023⁴⁶
• Morningside Venture Investments LtdSC 13D/A, 3 filings Feb 14, 2022 to Jul 25, 2023⁴⁷
• RPB VENTURES LLCSC 13D, 1 filing Jul 25, 2023⁴⁸
• Fares ZahirSC 13D/A, 2 filings Jun 8, 2023 to Jul 24, 2023⁴⁹
• Maria Helena LurantosSC 13D, 1 filing Jun 22, 2023⁵⁰
• Fall Line Endurance Fund, LPSC 13D/A, 3 filings Mar 30, 2023 to Jun 16, 2023⁵¹
• Carol FurneauxSC 13D, 1 filing Jun 14, 2023⁵²
• Cummings Foundation, Inc.SC 13D, 1 filing Jun 13, 2023⁵³
• David B. BrewsterSC 13D, 1 filing Jun 13, 2023⁵⁴
• Dennis A. ClarkeSC 13D, 1 filing Jun 13, 2023⁵⁵
• Eric Senior AndersonSC 13D, 1 filing Jun 13, 2023⁵⁶
• CG Investments Inc. VISC 13D, 1 filing Jun 12, 2023⁵⁷
• Anna Maria SenczukSC 13D, 2 filings Jun 8, 2023 to Jun 9, 2023⁵⁸
• Caitlin MacadinoSC 13D, 1 filing Jun 8, 2023⁵⁹
• Cormorant Global Healthcare Master Fund, LPSC 13D, 1 filing Jun 8, 2023⁶⁰
• Dharman Karthikeyan RamachandriyaSC 13D, 1 filing Jun 8, 2023⁶¹
• Himanshu Hemant DhamankarSC 13D, 1 filing Jun 8, 2023⁶²
• Ifeyinwa Jane IwuchukwuSC 13D, 1 filing Jun 8, 2023⁶³
• Jason Michael GillianSC 13D, 1 filing Jun 8, 2023⁶⁴
• Lewis & Clark Ventures I, LPSC 13D, 1 filing Jun 8, 2023⁶⁵
• Lorenzo AulisaSC 13D, 1 filing Jun 8, 2023⁶⁶
• May Carlos Alfredo GonzalezSC 13D, 1 filing Jun 8, 2023⁶⁷
• Michael C. RuettgersSC 13D, 1 filing Jun 8, 2023⁶⁸

SEC filer profile

How GreenLight Biosciences Holdings, PBC is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

• Name on EDGARGreenLight Biosciences Holdings, PBC¹
• CIK0001822691
• Employer ID (EIN)85-1914700¹
• Filer status<br>emerging growth company¹
• Incorporated inDelaware¹
• Fiscal year endsDecember 31¹
• Industry code (SIC)2836 Biological Products, (No Diagnostic Substances)¹
• Business address29 Hartwell Avenue, Lexington, MA 02421¹
• Phone(617) 616-8188¹
• Shares outstanding151,681,314 as of May 8, 2023⁶
• Public float$172.2M as of Jun 30, 2022³
• On EDGAR sinceSep 18, 2020¹
• Filings344 in all: 4 (73), 3 (62), SC 13D (45), 8-K (27), SC 13D/A (16), 424B3 (15), CORRESP (11), 425 (9)¹
  All 39 form types

  EFFECT (8), UPLOAD (8), 10-Q (7), S-4/A (5), SC 13G (5), SC 13G/A (5), 8-K/A (4), POS AM (4), SC 13E3/A (4), SC 14D9/A (4), 10-K (3), 4/A (3), S-1 (3), SC 13E3 (3), 10-Q/A (2), 25-NSE (2), SEC STAFF LETTER (2), 15-12G (1), 424B4 (1), 8-A12B (1), CERT (1), DRS (1), NT 10-Q (1), S-1/A (1), S-1MEF (1), S-4 (1), S-8 (1), S-8 POS (1), SC 14D9 (1), SC TO-T/A (1), SC14D9C (1)

• Latest filingsAnnual report (10-K) Mar 28, 2023
  Quarterly report (10-Q) May 11, 2023
  Latest 8-K (8-K) Jul 24, 2023